ThalesLab

ThalesLab is a Montevideo-based company builder and pre-seed investor that operates more like a venture studio than a traditional VC. The firm’s positioning is rooted in Uruguay’s small but technically deep talent pool: it focuses on high-complexity technology projects, including digital health and AI/ML applications, and tends to engage when founders need help converting research-grade ideas into commercially viable software companies. Check sizes are typically below $250k, which is consistent with how studios deploy: enough to fund a working team for several months alongside operational support rather than a syndicated priced round.

For healthcare AI founders, ThalesLab is most interesting if you are at the absolute earliest stage and want hands-on company-building help, not just a check. The firm is well-suited to teams with technical co-founders coming out of universities or research labs in Latin America who need help with productization, go-to-market structuring, and the unglamorous early infrastructure of becoming a startup. Founders who already have product-market fit, a complete team, and a priced seed lead lined up will find more capital and less hand-holding elsewhere.

Geographically, ThalesLab’s edge is regional. Uruguay is a small but stable jurisdiction with strong English-speaking technical talent and tax-favorable structures, which is part of why it has become a quiet base for LatAm AI teams. ThalesLab can plausibly help a founder navigate that environment, set up a corporate structure, and recruit from the local engineering scene. It is less obvious how much value the firm adds for a founder building primarily for the US healthcare system who has no LatAm operational footprint.

The right entry path is a warm intro from another portfolio founder or from a Uruguayan technical advisor; failing that, a precise note via the website explaining why the studio model fits your stage. Pitches should lead with the technical complexity of the problem and why a smaller, hands-on partner outperforms a larger seed firm at this moment. Soft data point to anchor: a working prototype or research validation that proves the team can ship.

Caveats worth noting. The public information about ThalesLab’s healthcare-specific portfolio is thin, so do diligence with founders the firm has previously backed before signing a studio agreement, since equity terms in builder structures vary widely. Confirm the specific check size, governance terms, and follow-on philosophy in writing before committing. For a healthcare AI founder, the studio model can be a strong accelerant when the team is technical and product-immature, and a poor fit when you already have your own operating cadence. The fact that the firm publicly emphasizes high-complexity technology projects rather than healthcare specifically also means you should expect a generalist filter on the partner reviewing the deal: be ready to translate clinical or regulatory nuance for someone who is sophisticated about deep tech but not necessarily about healthcare workflow. Used right, ThalesLab is a useful first institutional partner for a Uruguay-rooted team turning a prototype into a real company; used wrong, it is an awkward fit for founders who actually need a $1M+ priced seed and a healthcare-specialist board member.